Skip to main content
Clinical Trials/CTRI/2025/04/085340
CTRI/2025/04/085340Not yet recruitingNot Applicable

Intraoperative tissue separation and immediate visual quality following SMILE performed with VISUMAX800 using different energy and spot spacing parameters

ZEISS1 site in 1 country60 target enrollmentStarted: April 30, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
UCVA ,CVA

Study Overview

Brief Summary

Intra-operative tissue separation and immediate visual quality following

SMILE performed with VISUMAX 800 using different energy and spot spacing

parameters

A total of 30 non-consecutive patients will receive treatment with the following 6 groups of spot

separation settings, with n=5 patients ( n=10 eyes) in each group.

During and at the end of the procedure, the following parameters will be

evaluated:

  1. Time taken for laser delivery ( sec)

  2. Severity of the Opaque Bubble Layer( OBL) graded as <25%, <50%,

<75% and & 100%

  1. Ease of lenticule extraction using the “ No-dissection/ Lenticuloschisis

technique” on a grade of 1-5

4.Number of times Lenticuloschsis could not be performed or was

converted to conventional dissection technique.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
21.00 Year(s) to 40.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • myopia or myopic astigmatism between -2 to -10D.

Exclusion Criteria

  • patients with keratoconus, dry eye, PMD.

Outcomes

Primary Outcomes

UCVA ,CVA

Time Frame: pod1 , pod 15

MANIFEST FREFRACTION OSI MTF

Time Frame: pod1 , pod 15

Secondary Outcomes

  • OSI MTF(post op 3 months)

Investigators

Sponsor
ZEISS
Sponsor Class
Private hospital/clinic
Responsible Party
Principal Investigator
Principal Investigator

Dr Sri Ganesh

CONSULTANT , NETHRADHAMA SUPERSPECIALITY EYE HOSPITAL

Study Sites (1)

Loading locations...

Similar Trials